CG
RCKT icon

Cutler Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Cutler Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2K Buy
+8,000
New +$227K ﹤0.01% 1890
2021
Q3 		– Sell
-3,800
Closed -$13K – 6489
2021
Q2 		$13K Buy
3,800
+500
+15% +$21.7K ﹤0.01% 3693
2021
Q1 		$4K Buy
3,300
+3,000
+1,000% +$165K ﹤0.01% 4550
2020
Q4 		$5K Buy
+300
New +$10.9K ﹤0.01% 3690
2017
Q1 		– Sell
-2,750
Closed -$3K – 7243
2016
Q4 		$3K Sell
2,750
-6,875
-71% -$196K ﹤0.01% 5373
2016
Q3 		$105K Buy
9,625
+8,750
+1,000% +$275K 0.01% 1764
2016
Q2 		$1K Sell
875
-125
-13% -$4.39K ﹤0.01% 6211
2016
Q1 		$6K Sell
1,000
-2,700
-73% -$81K ﹤0.01% 4679
2015
Q4 		$4K Buy
+3,700
New +$161K ﹤0.01% 5101

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return